Inhibrx Inc
NASDAQ:INBX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Global Vectra Helicorp Ltd
NSE:GLOBALVECT
|
IN |
|
Kirloskar Oil Engines Ltd
NSE:KIRLOSENG
|
IN |
During the last 3 months Inhibrx Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 10% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/inbx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Oct 7, 2025
by
Viking Global Investors Lp
, who
sold
10m USD
worth of
INBX shares.
During the last 3 months Inhibrx Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 10% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/inbx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Oct 7, 2025
by
Viking Global Investors Lp
, who
sold
10m USD
worth of
INBX shares.
Inhibrx Inc
Glance View
Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The company is headquartered in La Jolla, California and currently employs 106 full-time employees. The company went IPO on 2020-08-19. The Company’s single domain antibody (sdAb) platform provides a small, simple, modular target binding domain that can be combined in to meet the needs of each biological target. Its products pipeline includes: INBRX-101 is a recombinant alpha-1 antitrypsin (AAT) protein that is comprised of two human AAT, molecules covalently linked to the fragment crystallizable (Fc) region of human immunoglobulin G4; INBRX-109 is a precisely engineered tetravalent sdAb-based therapeutic candidate targeting death-receptor 5 (DR5) that designed with its sdAb platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis, and INBRX-105 is a precisely engineered multi-specific sdAb-based therapeutic candidate that is designed to agonize 4-1BB selectively in the presence of PD-L1.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.